Lilly
  • Prescribing Information
  • Patient Prescribing Information
Menu closed
Lilly
  • Prescribing Information
  • Patient Prescribing Information
  • For Patients
  • House For Healthcare Providers
    • CYRAMZA® (ramucirumab)
    • ERBITUX® (cetuximab)
    • Jaypirca™ (pirtobrutinib)
    • Retevmo® (selpercatinib)
    • Verzenio® (abemaciclib)
    • Support and Resources
  • Contact Us


Support and Resources

Nurse looking over charts

FINANCIAL ASSISTANCE

Through the Lilly Oncology Support Center Savings Card program, commercially insured qualified patients pay as little as $0 (depending on the product) for their prescribed medication. There are no income requirements.

This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program. So if your patients are covered by Medicaid, Medicare Part D, TRICARE®, or any other state or federal program, they don’t meet the eligibility requirements.

Savings Card Eligibility Criteria†

ELIGIBLE

  • Patients must be aged 18 years or older
  • Patients must be residents of the United States or Puerto Rico
  • Patients must be treated with ALIMTA, CYRAMZA, ERBITUX, Jaypirca, Retevmo, or Verzenio for an FDA-approved indication
  • Patients must be commercially insured with coverage for ALIMTA, CYRAMZA, ERBITUX, Jaypirca, Retevmo, or Verzenio†

INELIGIBLE

  • Patients enrolled in Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program
  • Patients enrolled in any other financial support program, discount, discount card, or incentive program involving ALIMTA, CYRAMZA, ERBITUX, Jaypirca, Retevmo, or Verzenio
  • Patients, pharmacists, and prescribers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this program

†This offer is invalid for Patients without commercial drug insurance or whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Offer void where prohibited by law and subject to change or discontinuance without notice. Restrictions, including annual maximums, may apply. Card activation required.

Please see full terms and conditions for infused products.


Field Reimbursement Managers available through the Lilly Oncology Support Center

Lilly Field Reimbursement Managers can provide information and education to help navigate the access and reimbursement landscape. We’re here to help make access to prescribed Lilly Oncology products easier for patients.

If you have questions or want to learn more, call 1-866-472-8663, Monday - Friday, 8AM – 10PM ET.

Doctor with patients

OTHER TOOLS AND RESOURCES

Find other resources that may help you assist patients with reimbursement

When insurance isn’t enough to pay for cancer treatment, there are other resources that may help address the financial challenges and access issues that some patients experience.

Lilly Cares Foundation®

The Lilly Cares Foundation, Inc., a separate nonprofit organization, offers a patient assistance program to help qualifying patients receive Lilly medications at no cost. For more information about Lilly Cares, please visit LillyCares.com.


Independent Patient-Assistance Program Foundations

There may be a way to help your underinsured patients get the treatment they need with less financial stress. If your patients can’t afford their co-pay or coinsurance, the Lilly Oncology Support Center provides information about a number of independent patient-assistance programs that may be able to help eligible patients. These foundations are not affiliated with Eli Lilly and Company and have been established and are operated independently. Please remember, funding availability changes weekly, so contact a Lilly Oncology Support Center representative at 1-866-472-8663 for the most recent updates.

View Foundation List

BILLING AND CODING

Via the links below, arranged by product name, you’ll find billing codes and information related to ordering products.

Choose a product:

CYRAMZA® (ramucirumab)

ERBITUX® (cetuximab)

Jaypirca™ (pirtobrutinib)

Retevmo® (selpercatinib)

Verzenio® (abemaciclib)

Nurse and doctor

ADDITIONAL RESOURCES

Find the resources you need to navigate the appeals process

There are other tools and resources that can help as you work through the ordering, billing, reimbursement, and appeals processes.

Nurse and doctor


APPEALS RESOURCES

Find the resources you need to navigate the appeals process

If an insurance claim is denied, the Lilly Oncology Support Center can provide information to help you file an appeal on your patient’s behalf. We’ll help you understand what documents and information you’ll need and the deadlines you’ll have to meet.

If you have questions about filing an appeal, please call us at 1-866-472-8663.


Denied Claims Checklist

If a patient receives a denied explanation of benefits or an unfavorable response to a previous appeal, use this checklist to help you prepare an appeal packet.

Download Checklist


Letter of Medical Necessity Information

This guide provides important information needed in your letter of medical necessity to help facilitate the appeal process.

Download Letter


First-Level Appeal Letter for Commercial or Other Insurance

Use this template to create a request letter for a first-level appeal by an oncology medical advisor.

Download Appeal Letter


Second-Level Appeal Letter for Commercial or Other Insurance

If your patient’s first appeal was denied or he/she received an unfavorable response, use this letter template to initiate a second-level appeal.

Download Appeal Letter


First-Level Medicare Review Letter

If your patient was denied Medicare coverage, this letter template will help you request a redetermination by an oncology medical advisor.

Download Review Letter


Second-Level Medicare Review Letter

If your patient’s first Medicare review resulted in a denial or an unfavorable response, use this letter template to initiate a second-level review.

Download Review Letter

Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call 1-866-472-8663
Monday - Friday, 8am — 10pm ET

This site is intended for US healthcare professionals only.

PP-OC-US-0369 01/2023 ©Lilly USA, LLC 2023. All rights reserved.

ALIMTA®, CYRAMZA®, ERBITUX®, Retevmo®, and Verzenio® are registered trademarks and Jaypirca™ and Verzenio Continuous Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Other product/company names mentioned herein are the property of their respective owners.

Terms of UsePrivacy StatementAccessibility StatementSitemap
Lilly